Buys | $0 | 0 | 0 |
Sells | $25,543,609 | 17 | 100 |
McCormick Shawn | director | 0 | $0 | 1 | $176,000 | $-176,000 |
Griffin Jerry C | director | 0 | $0 | 3 | $223,650 | $-223,650 |
Buchholz Richard | Chief Financial Officer | 0 | $0 | 1 | $3.45M | $-3.45M |
Rondoni John | Chief Technology Officer | 0 | $0 | 7 | $4.03M | $-4.03M |
Herbert Timothy P. | CEO and President | 0 | $0 | 1 | $8.2M | $-8.2M |
Ban Randy | Chief Commercial Officer | 0 | $0 | 4 | $9.46M | $-9.46M |
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The …
Over the last 12 months, insiders at Inspire Medical Systems, Inc. have bought $0 and sold $25.54M worth of Inspire Medical Systems, Inc. stock.
On average, over the past 5 years, insiders at Inspire Medical Systems, Inc. have bought $15,350 and sold $67.45M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 100 shares for transaction amount of $15,350 was made by Sparks Charisse Y (Chief Medical Officer) on 2023‑10‑12.
2025-03-03 | Sale | Rondoni John | Chief Technology Officer | 2,287 0.0078% | $185.60 | $424,467 | -4.01% | |
2025-03-03 | Sale | Ban Randy | See Remarks | 3,947 0.0136% | $185.84 | $733,496 | -4.01% | |
2025-02-13 | Sale | Ban Randy | See Remarks | 25,584 0.0846% | $183.50 | $4.69M | -3.73% | |
2025-02-11 | Sale | Rondoni John | Chief Technology Officer | 583 0.0018% | $170.49 | $99,396 | +2.07% | |
2025-01-07 | Sale | Rondoni John | Chief Technology Officer | 58 0.0002% | $215.00 | $12,470 | -14.87% | |
2024-11-01 | Sale | Rondoni John | Chief Technology Officer | 8,703 0.0296% | $193.47 | $1.68M | -1.64% | |
2024-09-09 | Sale | McCormick Shawn | director | 800 0.0028% | $220.00 | $176,000 | -9.83% | |
2024-09-09 | Sale | Rondoni John | Chief Technology Officer | 31 0.0001% | $215.00 | $6,665 | -9.83% | |
2024-08-22 | Sale | Rondoni John | Chief Technology Officer | 5,000 0.0171% | $189.83 | $949,143 | +2.34% | |
2024-08-16 | Sale | Ban Randy | Chief Commercial Officer | 4,861 0.0158% | $188.55 | $916,549 | +1.04% | |
2024-08-15 | Sale | Ban Randy | Chief Commercial Officer | 16,139 0.0538% | $193.10 | $3.12M | +0.37% | |
2024-04-17 | Sale | Buchholz Richard | Chief Financial Officer | 15,000 0.0468% | $230.03 | $3.45M | -22.97% | |
2024-04-01 | Sale | Herbert Timothy P. | CEO and President | 40,000 0.1323% | $205.09 | $8.2M | -10.14% | |
2024-04-01 | Sale | Griffin Jerry C | director | 32 0.0001% | $213.99 | $6,848 | -10.14% | |
2024-03-25 | Sale | Griffin Jerry C | director | 554 0.0018% | $197.81 | $109,587 | -8.13% | |
2024-03-22 | Sale | Rondoni John | Chief Technology Officer | 4,387 0.0146% | $194.40 | $852,849 | -4.50% | |
2024-03-18 | Sale | Griffin Jerry C | director | 554 0.0018% | $193.53 | $107,216 | -5.27% | |
2024-03-11 | Sale | Griffin Jerry C | director | 554 0.0019% | $198.05 | $109,720 | -3.99% | |
2024-03-01 | Sale | Griffin Jerry C | director | 554 0.0018% | $179.44 | $99,410 | +3.21% | |
2024-02-29 | Sale | Rondoni John | Chief Technology Officer | 8,605 0.0289% | $179.25 | $1.54M | +5.73% |
Herbert Timothy P. | CEO and President | 63658 0.2146% | $10.32M | 1 | 30 | +89.73% |
Buchholz Richard | Chief Financial Officer | 28271 0.0953% | $4.58M | 1 | 19 | +89.73% |
McCormick Shawn | director | 23140 0.078% | $3.75M | 1 | 1 | +89.73% |
Ban Randy | See Remarks | 7259 0.0245% | $1.18M | 1 | 36 | +89.73% |
Amzak Health Investors, LLC | 10 percent owner | 1497043 5.0457% | $242.76M | 1 | 0 | +89.73% |
Increased Positions | 184 | +45.89% | 5M | +13.51% |
Decreased Positions | 174 | -43.39% | 4M | -12.21% |
New Positions | 63 | New | 2M | New |
Sold Out Positions | 48 | Sold Out | 701,728 | Sold Out |
Total Postitions | 411 | +2.49% | 34M | +1.29% |
Blackrock, Inc. | $779,725.00 | 14% | 4.2M | +83,184 | +2.02% | 2024-12-31 |
Vanguard Group Inc | $606,946.00 | 10.9% | 3.27M | +38,219 | +1.18% | 2024-12-31 |
Fmr Llc | $467,600.00 | 8.4% | 2.52M | -428,282 | -14.53% | 2024-12-31 |
Wasatch Advisors Lp | $245,306.00 | 4.41% | 1.32M | -1,705 | -0.13% | 2024-12-31 |
Baillie Gifford & Co | $233,102.00 | 4.19% | 1.26M | -110,830 | -8.11% | 2024-12-31 |
State Street Corp | $197,124.00 | 3.54% | 1.06M | +12,362 | +1.18% | 2024-12-31 |
William Blair Investment Management, Llc | $167,516.00 | 3.01% | 902,611 | -3,738 | -0.41% | 2024-12-31 |
Dragoneer Investment Group, Llc | $161,669.00 | 2.9% | 871,110 | +871,110 | New | 2024-12-31 |
Invesco Ltd. | $147,188.00 | 2.64% | 793,080 | +99,030 | +14.27% | 2024-12-31 |
Morgan Stanley | $108,501.00 | 1.95% | 584,628 | +221,321 | +60.92% | 2024-12-31 |